CClinicalTrials.gg
CompletedNCT04657627FOODSUpdated Oct 8, 2021

FOODS: Food shOppers' sOcial meDia Study

An interventional study of PACE plus calorie labelling information and Calorie-only labelling information in Eating Behaviour of Discretionary Foods, Cognitive Restraint of Eating and Physical Activity, sponsored by Loughborough University. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-10-08.

Sponsored by Loughborough University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
103
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to assess the effects of a new approach to food labelling called physical activity calorie equivalent (PACE) labelling. PACE food labelling provides the public with information about how many minutes (or miles/kilometres) of physical activity (e.g. walking or running) are equivalent to the calories contained in foods.

02

Conditions studied

  • Eating Behaviour of Discretionary Foods
  • Cognitive Restraint of Eating
  • Physical Activity
  • Body Weight

Browse trials for

Keywords

  • Nutrition labelling
  • Physical activity
  • Social media
03

In context

Body Weight

1,223 studies on the registry are indexed under Body Weight; 131 are open to participants now.

This study's enrollment of 103 is above the median of 64 across 947 interventional studies indexed under Body Weight.

Browse Body Weight studies →

Lead sponsor

Loughborough University is the lead sponsor of 71 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • ≥ 18 years old.
  • BMI of ≥ 18.5 kg/m2.
  • ≤ 3kg weight loss in previous 6 months.
  • Access and ability to use personal Twitter and/or Instagram account via own smartphone, computer or tablet device.
  • Access to the internet.
  • Access to a set of weighing scales.

Exclusion criteria

Exclusion Criteria:

  • Unable to read and understand English.
  • Experienced in the last 12 months or currently undergoing any of the following conditions or illnesses: coronary heart disease (CHD), hypertension, heart failure, stroke/transient ischaemic attack, atrial fibrillation, type 2 diabetes, chronic obstructive pulmonary disease (COPD), painful condition, dementia and cancer.
  • Had bariatric surgery.
  • Pregnant, lactating or planning to become pregnant in the next 12 months.
  • Parallel participation in another weight, dietary or physical activity intervention study.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
103 participants (actual)

Study arms

  • Experimental
    PACE plus calorie information intervention group

    PACE plus calorie information intervention group will receive PACE plus calorie information of discretionary foods via social media posts.

    Behavioral: PACE plus calorie labelling information

  • Active comparator
    Calorie-only information comparator group

    Calorie-only information comparator group will receive calorie-only information of discretionary foods via social media posts.

    Behavioral: Calorie-only labelling information

Interventions

  • BehavioralPACE plus calorie labelling information

    The intervention group will be exposed to PACE plus calorie labelling information via Instagram and Twitter social media posts every day for 13 weeks.

  • BehavioralCalorie-only labelling information

    The comparator group will be exposed to calorie-only labelling information via Instagram and Twitter social media posts every day for 13 weeks.

06

What researchers measure

Primary outcomes

  1. Change in eating behaviour of discretionary foods at 13 weeks

    Eating behaviour of discretionary foods will be assessed by a modified version of Online Food Frequency Questionnaire (eNutri FFQ), designed to measure habitual food intake. Participants will record frequencies of discretionary food and drink items eaten during the last month (e.g. "1/week" or "1/day").

    Time frame: Pre-baseline (one time point prior to randomisation) and post-intervention (one time point after week 13)

Secondary outcomes

  1. Cognitive restraint of eating

    A modified version (R18) of the Three-Factor Eating Questionnaire (TFEQ) will be used to measure cognitive restraint.

    Time frame: Pre-baseline (one time point prior to randomisation) and post-intervention (one time point after week 13)

  2. Physical activity

    Self-reported physical activity behaviour will be assessed using the 7-day International Physical Activity Questionnaire (IPAQ)

    Time frame: Pre-baseline (one time point prior to randomisation) and post-intervention (one time point after week 13)

  3. Body weight

    Weight will be self-reported via participants own weighing scales. Participants will electronically send via email photograph evidence of readings of their fasted morning weight from weighing scales, following standardised instructions.

    Time frame: Pre-baseline (one time point prior to randomisation), mid-intervention (week 7) and post-intervention (one time point after week 13)

07

Study locations

1 site
  • Loughborough University
    Loughborough, Leicestershire LE11 3TU, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04657627
Lead sponsor
Loughborough University
Collaborators
Dr Oonagh Markey, Alexandra Todd
Responsible party
Amanda Daley (Professor Amanda Daley, Loughborough University) — Principal investigator
First posted
Dec 8, 2020
Start date
Jan 6, 2021
Primary completion
Sep 30, 2021
Completion
Oct 4, 2021
Last update
Oct 8, 2021

Study contacts

Amanda Daley
principal investigator · Loughborough University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion